Ignorant question: why do biotech companies IPO so early? (Often before their first drug is in the clinic). I would have thought that would be a costly process for a company still facing serious technical risk ahead.
-
-
I think that's fair -- relatively less valuable. If you can find patient, qualified capital and well-placed, confident mgmt to concur on great deal terms, it's great.
- 2 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.